Wednesday, 8 June 2016

US Agency charges Dr. Reddy’s Labs for packaging lapses; company disagrees

The US Consumer Product Safety Commission (US CPSC), which is tasked with protecting children and families from risks of injuries or death associated with consumer products,
had taken issue with the company's compliance norms that required special packaging for child resistant blister packs for products sold in the US over several years.

"The safety of patients and consumers is of paramount importance to Dr. Reddy's. The company is not aware of any reports that any child gained access to these products as a result of the packaging or that any of the products caused children harm as a result of the packaging.
Dr. Reddy's believes that it has complied with all applicable requirements of the Consumer Product Safety Act, including applicable packaging and reporting requirements," it added. A questionnaire sent to US CPSC media representative was not answered by press­time. Established by the US Congress in 1972, the CPSC is a federal regulatory body and claims to have been effective in reducing consumer product­related injury and death rates by using a wide range of strategies to identify and address product safety hazards.

In a June 2014 filing with the US Securities Exchange Commission, Dr. Reddy's had denied any violations, noting it disagreed with CPSC's allegations and that it is engaged in discussions regarding its compliance with the regulations. "An unfavourable outcome in these matters could result in significant liabilities, which could have a material adverse effect on the company," the company said in the same filing in 2014. 

No comments:

Post a Comment